8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Feb 12, 2026)

Filed February 12, 2026For Securities:DXCM

Summary

DexCom, Inc. (DXCM) has filed an 8-K report on February 12, 2026, to announce its financial results for the fourth quarter and full year ended December 31, 2025. The primary purpose of this filing is to furnish the accompanying press release, which contains key financial and operational updates for investors. Investors should refer to the press release (Exhibit 99.1) for the detailed financial performance, strategic initiatives, and forward-looking statements made by the company. While the specific financial figures are not detailed within the 8-K text itself, this report signals the company's official communication of its year-end and quarterly performance. The furnishing of this information means it is provided for informational purposes and is not deemed "filed" under the Securities Exchange Act of 1934, thus not subject to specific liability sections of that act. Investors are advised to carefully review the press release for comprehensive details on revenue, profitability, product development, and any guidance for the upcoming fiscal year.

Key Highlights

  • 1DexCom, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025, via an 8-K filing on February 12, 2026.
  • 2The report includes a press release (Exhibit 99.1) containing detailed financial results and other relevant information.
  • 3This filing is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
  • 4Investors should consult Exhibit 99.1 for specific financial performance data, operational updates, and potential forward-looking statements.
  • 5The company is providing investors with its official year-end and quarterly performance update.
  • 6The filing does not incorporate the furnished information by reference into other DexCom filings, except as expressly stated.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce and provide investors with DexCom's financial results for the fourth quarter and the full fiscal year ended December 31, 2025. This is achieved by furnishing a press release that contains these details.

The specific financial results, operational highlights, and any forward-looking statements are located in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for comprehensive information.

The information in this Item 2.02, including the press release, is furnished and therefore is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it is not subject to the liabilities associated with that specific section.

No, the information contained in this 8-K filing and its accompanying exhibit is not automatically incorporated by reference into any future DexCom filings under the Securities Act of 1933 or the Exchange Act, unless specifically stated otherwise in such future filings.